BMC Cancer

official impact factor 3.15

Open Access Highly Access Study protocol

Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT) – phase I/II trial: study protocol

Stephanie E Combs*, Steffen Heeger, Renate Haselmann, Lutz Edler, Jürgen Debus and Daniela Schulz-Ertner

BMC Cancer 2006, 6:133 doi:10.1186/1471-2407-6-133

No comments have yet been made on this article.

Post a comment